These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 7730221)

  • 1. Synergic inhibitory activity of amphotericin-B and gamma interferon against intracellular Cryptococcus neoformans in murine macrophages.
    Herrmann JL; Dubois N; Fourgeaud M; Basset D; Lagrange PH
    J Antimicrob Chemother; 1994 Dec; 34(6):1051-8. PubMed ID: 7730221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancement of nitric oxide synthesis by macrophages represents an additional mechanism of action for amphotericin B.
    Mozaffarian N; Berman JW; Casadevall A
    Antimicrob Agents Chemother; 1997 Aug; 41(8):1825-9. PubMed ID: 9257771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiphagocytic protein 1 increases the susceptibility of Cryptococcus neoformans to amphotericin B and fluconazole.
    Ghaffar M; Orr C; Webb G
    PLoS One; 2019; 14(12):e0225701. PubMed ID: 31800598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of Mycograb, amphotericin B, caspofungin, and fluconazole in combination against Cryptococcus neoformans by checkerboard and time-kill methodologies.
    Nooney L; Matthews RC; Burnie JP
    Diagn Microbiol Infect Dis; 2005 Jan; 51(1):19-29. PubMed ID: 15629225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticryptococcal effect of amphotericin B is mediated through macrophage production of nitric oxide.
    Tohyama M; Kawakami K; Saito A
    Antimicrob Agents Chemother; 1996 Aug; 40(8):1919-23. PubMed ID: 8843304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro antifungal activities of amphotericin B, 5-fluorocytosine, fluconazole and itraconazole against Cryptococcus neoformans isolated from cerebrospinal fluid and blood from patients in Serbia.
    Trpković A; Pekmezović M; Barać A; Crnčević Radović L; Arsić Arsenijević V
    J Mycol Med; 2012 Sep; 22(3):243-8. PubMed ID: 23518082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A sub-inhibitory concentration of amphotericin B enhances candidastatic activity of interferon-gamma- and interleukin-13-treated murine peritoneal macrophages.
    Coste A; Linas MD; Cassaing S; Bernad J; Chalmeton S; Séguéla JP; Pipy B
    J Antimicrob Chemother; 2002 May; 49(5):731-40. PubMed ID: 12003965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antifungal pharmacodynamic characteristics of fluconazole and amphotericin B against Cryptococcus neoformans.
    Klepser ME; Wolfe EJ; Pfaller MA
    J Antimicrob Chemother; 1998 Mar; 41(3):397-401. PubMed ID: 9578168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The in vitro effects of interferon-gamma, alone or in combination with amphotericin B, tested against the pathogenic fungi Candida albicans and Aspergillus fumigatus.
    El-Khoury M; Ligot R; Mahoney S; Stack CM; Perrone GG; Morton CO
    BMC Res Notes; 2017 Aug; 10(1):364. PubMed ID: 28764751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increasing in vitro resistance to fluconazole in Cryptococcus neoformans Cambodian isolates: April 2000 to March 2002.
    Sar B; Monchy D; Vann M; Keo C; Sarthou JL; Buisson Y
    J Antimicrob Chemother; 2004 Aug; 54(2):563-5. PubMed ID: 15254027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antifungal susceptibility of Cryptococcus neoformans to amphotericin B and fluconazole.
    Khyriem AB; Sujatha S; Parija SC
    Indian J Pathol Microbiol; 2006 Apr; 49(2):307-8. PubMed ID: 16933750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluconazole vs amphotericin B: "in vitro" comparative evaluation of the minimal inhibitory concentration (MIC) against yeasts isolated from AIDS patients.
    Lombardi G; Gramegna G; Cavanna C; Michelone G
    Microbiologica; 1990 Jul; 13(3):201-6. PubMed ID: 2273982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cryptococcus neoformans fails to induce nitric oxide synthase in primed murine macrophage-like cells.
    Naslund PK; Miller WC; Granger DL
    Infect Immun; 1995 Apr; 63(4):1298-304. PubMed ID: 7534274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergic effect of simvastatin in combination with amphotericin B against environmental strains of Cryptococcus neoformans from northeastern Brazil: a prospective experimental study.
    Silva THS; Araújo CV; Santos KMDC; Alves NDS; Gomes THS; Silva AKFE; Silva NCLDS; Damasceno Júnior ECB; Carvalho AMA; Mendes MGA; Caminha HB; Daboit TC; Ferreira TB; Andrade-Silva LE; Silva-Vergara ML; Ferreira-Paim K; Fonseca FM
    Sao Paulo Med J; 2020; 138(1):40-46. PubMed ID: 32321104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fungicidal activity of IFN-gamma-activated macrophages. Extracellular killing of Cryptococcus neoformans.
    Flesch IE; Schwamberger G; Kaufmann SH
    J Immunol; 1989 May; 142(9):3219-24. PubMed ID: 2496162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amphotericin B and fluconazole affect cellular charge, macrophage phagocytosis, and cellular morphology of Cryptococcus neoformans at subinhibitory concentrations.
    Nosanchuk JD; Cleare W; Franzot SP; Casadevall A
    Antimicrob Agents Chemother; 1999 Feb; 43(2):233-9. PubMed ID: 9925511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serotypes of clinical cerebrospinal fluid Cryptococcus neoformans isolates from southern Taiwan and their in vitro susceptibilities to amphotericin B, fluconazole, and voriconazole.
    Chang WN; Huang CR; Lei CB; Lee PY; Chien CC; Chang HW; Chang CS; Lu CH
    Jpn J Infect Dis; 2004 Jun; 57(3):113-5. PubMed ID: 15218221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activity of amphotericin B, fluconazole and voriconazole against 162 Cryptococcus neoformans isolates from Africa and Cambodia.
    Chandenier J; Adou-Bryn KD; Douchet C; Sar B; Kombila M; Swinne D; Thérizol-Ferly M; Buisson Y; Richard-Lenoble D
    Eur J Clin Microbiol Infect Dis; 2004 Jun; 23(6):506-8. PubMed ID: 15141336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fungicidal properties of defensin NP-1 and activity against Cryptococcus neoformans in vitro.
    Alcouloumre MS; Ghannoum MA; Ibrahim AS; Selsted ME; Edwards JE
    Antimicrob Agents Chemother; 1993 Dec; 37(12):2628-32. PubMed ID: 8109927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antifungal susceptibilities of Cryptococcus neoformans cerebrospinal fluid isolates and clinical outcomes of cryptococcal meningitis in HIV-infected patients with/without fluconazole prophylaxis.
    Manosuthi W; Sungkanuparph S; Thongyen S; Chumpathat N; Eampokalap B; Thawornwan U; Foongladda S
    J Med Assoc Thai; 2006 Jun; 89(6):795-802. PubMed ID: 16850679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.